141 related articles for article (PubMed ID: 32488234)
1. Low Serum Naproxen Concentrations Are Associated with Minimal Pain Relief: A Preliminary Study in Women with Dysmenorrhea.
Oladosu FA; Tu FF; Garrison EF; Dillane KE; Roth GE; Hellman KM
Pain Med; 2020 Nov; 21(11):3102-3108. PubMed ID: 32488234
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies.
Milsom I; Minic M; Dawood MY; Akin MD; Spann J; Niland NF; Squire RA
Clin Ther; 2002 Sep; 24(9):1384-400. PubMed ID: 12380631
[TBL] [Abstract][Full Text] [Related]
3. Abdominal skeletal muscle activity precedes spontaneous menstrual cramping pain in primary dysmenorrhea.
Oladosu FA; Tu FF; Farhan S; Garrison EF; Steiner ND; Roth GE; Hellman KM
Am J Obstet Gynecol; 2018 Jul; 219(1):91.e1-91.e7. PubMed ID: 29733841
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain.
Cockrum RH; Tu FF; Kierzkowska O; Leloudas N; Pottumarthi PV; Hellman KM
Am J Obstet Gynecol; 2024 May; 230(5):553.e1-553.e14. PubMed ID: 38295969
[TBL] [Abstract][Full Text] [Related]
5. A crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea.
Mehlisch DR; Fulmer RI
J Womens Health; 1997 Feb; 6(1):83-92. PubMed ID: 9065377
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review.
Zahradnik HP; Hanjalic-Beck A; Groth K
Contraception; 2010 Mar; 81(3):185-96. PubMed ID: 20159173
[TBL] [Abstract][Full Text] [Related]
7. Naproxen, paracetamol and pamabrom versus paracetamol, pyrilamine and pamabrom in primary dysmenorrhea: a randomized, double-blind clinical trial.
Ortiz MI; Murguía-Cánovas G; Vargas-López LC; Silva R; González-de la Parra M
Medwave; 2016 Oct; 16(9):e6587. PubMed ID: 27813503
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
9. Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.
Daniels SE; Torri S; Desjardins PJ
J Gen Intern Med; 2005 Jan; 20(1):62-7. PubMed ID: 15693930
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a real-time method characterizing spontaneous pain in women with dysmenorrhea.
Kantarovich D; Dillane KE; Garrison EF; Oladosu FA; Schroer MS; Roth GE; Tu FF; Hellman KM
J Obstet Gynaecol Res; 2021 Apr; 47(4):1472-1480. PubMed ID: 33590541
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea.
Letzel H; Mégard Y; Lamarca R; Raber A; Fortea J
Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):162-8. PubMed ID: 16675091
[TBL] [Abstract][Full Text] [Related]
12. Significant, long-lasting pain relief in primary dysmenorrhea with low-dose naproxen sodium compared with acetaminophen: a double-blind, randomized, single-dose, crossover study.
Daniels SE; Paredes-Diaz A; An R; Centofanti R; Tajaddini A
Curr Med Res Opin; 2019 Dec; 35(12):2139-2147. PubMed ID: 31397597
[No Abstract] [Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea.
Dawood MY
Am J Med; 1988 May; 84(5A):23-9. PubMed ID: 3287908
[TBL] [Abstract][Full Text] [Related]
14. Treating dysmenorrhea with anti-inflammatory agents: a double-blind trial with naproxen sodium.
Sande HA; Salvesen T; Izu A
Int J Gynaecol Obstet; 1978-1979; 16(3):240-1. PubMed ID: 33086
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed.
Owen PR
Am J Obstet Gynecol; 1984 Jan; 148(1):96-103. PubMed ID: 6419611
[TBL] [Abstract][Full Text] [Related]
16. Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.
Hanson FW; Izu A; Henzl MR
Obstet Gynecol; 1978 Nov; 52(5):583-7. PubMed ID: 364357
[TBL] [Abstract][Full Text] [Related]
17. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.
Selçuk E; Gomel M; Apaydin S; Köse T; Tuglular I
Int J Clin Pharmacol Res; 1998; 18(1):21-9. PubMed ID: 9604731
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea: A network meta-analysis.
Nie W; Xu P; Hao C; Chen Y; Yin Y; Wang L
Medicine (Baltimore); 2020 May; 99(19):e19881. PubMed ID: 32384431
[TBL] [Abstract][Full Text] [Related]
19. Valdecoxib: a review.
Chavez ML; DeKorte CJ
Clin Ther; 2003 Mar; 25(3):817-51. PubMed ID: 12852704
[TBL] [Abstract][Full Text] [Related]
20. Naproxen sodium for OB/GYN use, with special reference to pain states: a review.
Edgren RA; Morton CJ
Int J Fertil; 1986; 31(2):135-42. PubMed ID: 2875035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
